$13.32
0.09[0.68%]
At close: Apr 19
$13.32
0[0.00%]
After Hours: 4:00PM EDT
Enanta Pharma
(NASDAQ:ENTA)Latest News for Enanta Pharma Stock (NASDAQ:ENTA)
Enanta Pharma Stock (NASDAQ: ENTA)
Categories: All
Thursday, February 08, 2024
Wednesday, February 07, 2024
Tuesday, February 06, 2024
Thursday, January 04, 2024
Thursday, November 23, 2023
Wednesday, November 22, 2023
Tuesday, November 21, 2023
- Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Nov 21, 2023, 1:28PM
- Enanta Pharmaceuticals shares are trading higher after the company reported better-than-expected Q4 revenue results.Benzinga Newsdesk - Nov 21, 2023, 12:24PM
- What 5 Analyst Ratings Have To Say About Enanta PharmaBenzinga Insights - Nov 21, 2023, 9:00AM
- HC Wainwright & Co. Maintains Buy on Enanta Pharma, Lowers Price Target to $28Benzinga Newsdesk - Nov 21, 2023, 6:53AM
- JMP Securities Maintains Outperform on Enanta Pharma, Lowers Price Target to $23Benzinga Newsdesk - Nov 21, 2023, 6:51AM
Monday, November 20, 2023
Friday, November 17, 2023
Monday, October 23, 2023
Tuesday, October 10, 2023
Thursday, October 05, 2023
Tuesday, October 03, 2023
Thursday, September 28, 2023
Tuesday, September 19, 2023
Monday, September 18, 2023
Thursday, September 07, 2023
Wednesday, September 06, 2023
Tuesday, September 05, 2023
- Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Sep 5, 2023, 1:34PM
- Stocks That Hit 52-Week Lows On TuesdayBenzinga Insights - Sep 5, 2023, 1:34PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Sep 5, 2023, 1:31PM
- Enanta Pharmaceuticals shares are trading lower after it was announced the company will be replaced in the S&P SmallCap 600.Benzinga Newsdesk - Sep 5, 2023, 1:04PM
Monday, August 14, 2023
Wednesday, August 09, 2023
Tuesday, August 08, 2023
- Stocks That Hit 52-Week Lows On TuesdayBenzinga Insights - Aug 8, 2023, 1:32PM
- Enanta Pharmaceuticals shares are trading lower after the company reported Q3 financial results. Additionally, Jefferies downgraded the stock from Buy to Hold and lowered its price target from $49 to $18.Benzinga Newsdesk - Aug 8, 2023, 1:14PM
- HC Wainwright & Co. Reiterates Buy on Enanta Pharma, Maintains $48 Price TargetBenzinga Newsdesk - Aug 8, 2023, 12:20PM
- RBC Capital Reiterates Sector Perform on Enanta Pharma, Maintains $25 Price TargetBenzinga Newsdesk - Aug 8, 2023, 11:30AM
- Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023Benzinga Insights - Aug 8, 2023, 11:00AM
- JMP Securities Maintains Market Outperform on Enanta Pharma, Lowers Price Target to $42Benzinga Newsdesk - Aug 8, 2023, 9:46AM
- DraftKings To Rally Over 38%? Here Are 10 Other Analyst Forecasts For TuesdayLisa Levin - Aug 8, 2023, 7:43AM
- Jefferies Downgrades Enanta Pharma to Hold, Lowers Price Target to $18Benzinga Newsdesk - Aug 8, 2023, 5:40AM